DUBLIN–(BUSINESS WIRE)–“An Essential Overview of the Pharmaceutical and Biotech Industries Training Course (Mar 12, 2026)” has been added to ResearchAndMarkets.DUBLIN–(BUSINESS WIRE)–“An Essential Overview of the Pharmaceutical and Biotech Industries Training Course (Mar 12, 2026)” has been added to ResearchAndMarkets.

1 Day Essential Overview of the Pharmaceutical and Biotech Industries Training Course (ONLINE EVENT: March 12, 2026) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–“An Essential Overview of the Pharmaceutical and Biotech Industries Training Course (Mar 12, 2026)” has been added to ResearchAndMarkets.com’s offering.

The pharmaceutical and biotechnology industries are both complex and developing at a rapid pace.

This intensive one-day course will give you an invaluable overview, refresher and update on all the important aspects from discovery of the molecule through development to marketing. The interactive programme will provide a step-by-step understanding of the main areas of drug development and will discuss the roles and responsibilities of key departments and how they work and interact together.

There will be interactive discussion sessions throughout the day, led by our expert course leader, and you will come away with a good knowledge of the structure and function of these industries.

Who Should Attend:

This event will be of interest to all those looking to develop their knowledge of how the pharmaceutical and biotechnology industries work. It will be particularly helpful for those wanting to understand what other departments do, for new staff working in the industry and for non-scientific and administrative personnel.

Why you should attend

  • Increase your understanding of the pharma/biotech industries
  • Develop your knowledge of the stages of drug development from drug discovery through to marketing
  • Get to grips with the phases of clinical trials, regulatory processes and pharmacovigilance requirements
  • Understand the roles and responsibilities of key departments and how they work together
  • Demystify the technical terminology and jargon

Certification:

  • CPD: 6 hours for your records
  • Certificate of completion

Key Topics Covered:

How the Pharma/Biotech Industries Develop Medicines

  • Overview of drug development
  • Framework of the industry – research, development and manufacture of pharma products on an international level
  • Difference between pharma and biotech drug development
  • Drug discovery
  • Non-clinical/pre-clinical – the importance of examining safety
  • Technologies and innovations across the industry

Demystifying the Jargon and Terminology

Roles and Responsibilities of the People in the Pharma/Biotech Industries

Clinical Trials

  • Phases of clinical research – phase 1 to Phase IV and range of clinical trials
  • Setting up and running of clinical trials
  • Quality of the data – monitoring, auditing and compliance with GCP innovations in running clinical trials

Pharmacovigilance

  • Understanding safety reporting and signal detection
  • Definitions and periodic and drug safety update reports

Regulatory Processes

  • Overview of regulatory submissions and approval procedures for pharma/biotech products including EU and FDA procedures
  • The importance of ICH including the electronic Common Technical Document (eCTD)
  • The EU Clinical Trial Regulation

Commercial Considerations for How Medicines are Marketed and Sold

  • Marketing terminology and activities

Speakers:

Laura Brown

Pharmaceutical QA and Training Consultant

University of Cardiff

Dr Laura Brown MBA, BSc, PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.

She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.

For more information about this training visit https://www.researchandmarkets.com/r/ltwv29

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Market Opportunity
1 Logo
1 Price(1)
$0.008211
$0.008211$0.008211
-0.89%
USD
1 (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Will Bitcoin Soar or Stumble Next?

Will Bitcoin Soar or Stumble Next?

The post Will Bitcoin Soar or Stumble Next? appeared on BitcoinEthereumNews.com. With the Federal Reserve’s forthcoming decision on interest rates causing speculation, Bitcoin‘s value remains stable at $115,400. China’s surprising maneuvers in the financial landscape have shifted expected market trends, prompting deeper examination by investors into analysts’ past evaluations regarding rate reductions. Continue Reading:Will Bitcoin Soar or Stumble Next? Source: https://en.bitcoinhaber.net/will-bitcoin-soar-or-stumble-next
Share
BitcoinEthereumNews2025/09/18 03:09
BDACS unveils KRW-backed stablecoin KRW1 on Avalanche

BDACS unveils KRW-backed stablecoin KRW1 on Avalanche

The post BDACS unveils KRW-backed stablecoin KRW1 on Avalanche appeared on BitcoinEthereumNews.com. Key Takeaways BDACS has launched KRW1, the first Korean won-backed stablecoin on the Avalanche blockchain. KRW1 is fully backed by Korean won reserves held at Woori Bank. South Korea’s BDACS launched KRW1, the first Korean won-backed stablecoin on the Avalanche blockchain. The digital asset is fully collateralized with Korean won held at Woori Bank. The launch follows successful proof of concept validation, marking one of the first stablecoins pegged to South Korea’s national currency to operate on a major blockchain network. Source: https://cryptobriefing.com/bdacs-krw1-stablecoin-avalanche-launch/
Share
BitcoinEthereumNews2025/09/18 11:55
Zcash Consolidates After Rejection as Traders Brace for Breakout

Zcash Consolidates After Rejection as Traders Brace for Breakout

The post Zcash Consolidates After Rejection as Traders Brace for Breakout appeared on BitcoinEthereumNews.com. ZEC compression persists as higher lows hold, signaling
Share
BitcoinEthereumNews2025/12/29 20:30